ArticleLung cancer (Amsterdam, Netherlands)2025

Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study.

Ibiayi Dagogo-Jack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.